Associate Professor Chong Qiu, Ph.D., is a prominent researcher at the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing. He earned his bachelor’s and doctoral degrees from the School of Pharmaceutical Science, Peking University, in 2014 and 2019, respectively. Dr. Qiu’s research focuses on advanced nanocarriers for targeted drug delivery, including siRNA and protein delivery systems. He is an active Young Scientist Board Member for several journals and has published extensively, with notable papers in Nature Communications and Journal of Nanobiotechnology. His work has garnered significant attention and impact in the fields of nanomedicine and drug delivery.
Professional Profile:
Orcid
Suitability Summary for Young Scientist Award: Associate Professor Chong Qiu
Associate Professor Chong Qiu is an exemplary candidate for the Young Scientist Award. His pioneering research in nanocarriers for drug delivery, combined with his impressive publication record and leadership roles, highlights his exceptional potential and influence in the scientific community. His achievements and innovative contributions make him a standout nominee for this prestigious award
šEducation:
Dr. Chong Qiu earned his Ph.D. in Pharmaceutical Sciences from the School of Pharmaceutical Science at Peking University, Beijing, China, in 2019. He completed his Bachelorās Degree in Pharmaceutical Sciences at the same institution in 2014.
š¢Work Experience:
Dr. Chong Qiu has been serving as an Associate Professor at the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, since 2019. In addition to his role at the Research Center, he is an ongoing Young Scientist Board Member for the Asian Journal of Pharmaceutical Sciences, iMeta, and Traditional Medicine Research and Exploration
š
Awards and Recognition:
Dr. Chong Qiu has an extensive publication record in high-impact journals, including notable works in Nature Communications and the Journal of Nanobiotechnology. His research has garnered significant recognition and has made substantial contributions to the fields of nanomedicine and drug delivery.
Publication Top Notes:
-
Photoaffinity Probe-Based Antimalarial Target Identification of Artemisinin in the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
-
Enhanced Tumor Penetration Across the Blood-Brain Barrier: Endoplasmic Reticulum Membrane Hybrid siRNA Nanoplexes
-
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
-
Advanced Strategies for Nucleic Acids and Small-Molecular Drugs in Combined Anticancer Therapy
-
Anemoside B4 Alleviates Neuropathic Pain Through Inhibiting Inflammation